Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PDEXthis companyPro-Dex, Inc.	$65.18	13.81×	3.97×	2.44×	13.82×	122.5%	31.4%	16.8%	17.6%	28.7%	15.0%	3.6%	0.38×	0.69×	16×	4.1×	0.0%	6	7.36	4	A
APYXApyx Medical Corporation	$2.98	-12.96×	10.15×	2.79×	-33.8×	-284.7%	36.0%	-12.2%	-21.2%	-77.1%	-11.6%	-6.2%	2.71×	-1.66×	-1.15×	5×	0.0%	3	0.84	1	D+
CGTXCognition Therapeutics, Inc.	$0.69	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
GLSIGreenwich LifeSciences, Inc.	$15.44	-14.69×	805.09×	0×	-14.37×	-99.2%	0.0%	0.0%	0.0%	-5480.5%	-5505.9%	-3.5%	0×	0.32×	0×	1.06×	0.0%	1	2.27	1	D+
LUCDLucid Diagnostics Inc.	$0.40	-1.58×	10.16×	23.61×	-1.79×	-873.4%	-60.3%	-1054.8%	-1232.7%	-530.4%	-135.1%	-41.8%	2.36×	0.16×	-2,256.36×	1.31×	0.0%	3	-13.58	2	C
MBOTMicrobot Medical Inc.	$1.09	-6.9×	1.18×	0×	-6.76×	-93.0%	0.0%	0.0%	0.0%	-16.9%	-18.8%	-14.3%	0.01×	0.23×	0×	23.33×	0.0%	2	8.03	2	C+
Peer median	—	-6.9×	10.15×	0×	-6.76×	-99.2%	0.0%	0.0%	0.0%	-77.1%	-135.1%	-14.3%	0.02×	0.23×	-1.15×	3.45×	0.0%	2	0.84	2	—